Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
+ Facility Inspections FDA Warning Letters Company: Apothecary Pharma, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: December 1, 2025
Howatson G, Bell PG, Tallent J, Middleton B, McHugh MP, Ellis J
Custom-compounded for stability
Include consult fees, surgeon or practitioner fees, anesthesia, facility fees, and recovery supplies
ABOUT ONLINE RETATRUTIDE This website provides current, evidence-based insights into emerging clinical research in obesity care, including investigational compounds such as retatrutide evaluated within controlled study settings
If you miss a dose, contact your provider at the Institute for Hormonal Balance
US$ 25.92
US$ 26.52
US$ 21.23
US$ 24.91
US$ 24.01
